Insmed Inc (INSM)vsUniqure NV (QURE)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
QURE
Uniqure NV
$16.36
+7.77%
HEALTHCARE · Cap: $949.20M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 3667% more annual revenue ($606.42M vs $16.10M). QURE leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
QURE
Avoid22
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -2.1% — below average capital efficiency
Earnings declined 18.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : QURE
QURE has a balanced fundamental profile.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : QURE
The primary concerns for QURE are Market Cap, Profit Margin, Return on Equity.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while QURE is a value play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
QURE is growing revenue faster at 6.6% — sustainability is the question.
QURE generates stronger free cash flow (-78M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 22/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Uniqure NV
HEALTHCARE · BIOTECHNOLOGY · USA
uniQure NV, a gene therapy company, is dedicated to developing treatments for patients suffering from genetic and other devastating diseases. The company is headquartered in Amsterdam, the Netherlands.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?